NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/nhs-fund-ruxolitinib-vitiligo-2026a10005sg?src=rss
Author :
Publish date : 2026-02-24 13:38:00
Copyright for syndicated content belongs to the linked Source.